Nguyen Hao G相关文献与解析，生知库 | 链接生命科学的每一步

Kuzuoglu-Ozturk Duygu, Nguyen Hao G, Xue Lingru, Figueredo Emma, Subramanyam Vishvak, Liu Isabelle, Bonitto Kenya, Noronha Ashish, Dabrowska Adrianna, Cowan Janet E, Oses-Prieto Juan A, Burlingame Alma L, Worland Stephen T, Carroll Peter R, Ruggero Davide

肿瘤

前列腺癌

肿瘤免疫

发表日期：2025

文献求助收藏

Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma

原发性前列腺腺癌选择性前列腺动脉和静脉注射PSMA PET/CT放射性配体输注的药代动力学比较

期刊:Radiology

影响因子:15.2

doi:10.1148/radiol.232544

Kohlbrenner, Ryan; Wu, Xiao; Nguyen, Hao G; Cooperberg, Matthew R; Chakravarty, Tushar; Carroll, Peter R; Hope, Thomas A

The natural history of a delayed detectable PSA after radical prostatectomy

根治性前列腺切除术后延迟检测到PSA的自然史

期刊:Prostate Cancer and Prostatic Diseases

影响因子:5.8

doi:10.1038/s41391-022-00638-y

Szymaniak, Julie A; Washington, Samuel L 3rd; Cowan, Janet E; Cooperberg, Matthew R; Lonergan, Peter E; Nguyen, Hao G; Meng, Maxwell V; Carroll, Peter R

PSA

发表日期：2023

文献求助收藏

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial

在2期临床试验中，恩扎卢胺联合亮丙瑞林和根治性放射治疗对高危局限性或区域性非转移性前列腺癌具有良好的耐受性和疗效。

期刊:Advances in Radiation Oncology

影响因子:2.7

doi:10.1016/j.adro.2022.100941

Shee, Kevin; de la Calle, Claire M; Chang, Albert J; Wong, Anthony C; Feng, Felix Y; Gottschalk, Alexander R; Carroll, Peter R; Nguyen, Hao G

US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy

美国超声病灶可见性可预测系统性活检所显示的具有临床意义的前列腺癌分级升级

期刊:Abdominal Radiology

影响因子:2.2

doi:10.1007/s00261-021-03389-x

Velarde, Nathan; Westphalen, Antonio C; Nguyen, Hao G; Neuhaus, John; Shinohara, Katsuto; Simko, Jeffry P; Larson, Peder E; Magudia, Kirti

Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial

68Ga-PSMA-11 PET在根治性前列腺切除术和盆腔淋巴结清扫术前检测盆腔淋巴结转移的诊断准确性：一项多中心前瞻性3期影像学试验

期刊:Jama Oncology

影响因子:20.1

doi:10.1001/jamaoncol.2021.3771

Hope, Thomas A; Eiber, Matthias; Armstrong, Wesley R; Juarez, Roxanna; Murthy, Vishnu; Lawhn-Heath, Courtney; Behr, Spencer C; Zhang, Li; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenböck, Sarah M; Unterrainer, Marcus; Zacho, Helle D; Nguyen, Hao G; Cooperberg, Matthew R; Carroll, Peter R; Reiter, Robert E; Holden, Stuart; Herrmann, Ken; Zhu, Shaojun; Fendler, Wolfgang P; Czernin, Johannes; Calais, Jeremie

发表日期：2021

文献求助收藏

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

评估 68Ga-PSMA-11 PET 在定位复发性前列腺癌中的准确性：一项前瞻性单臂临床试验

期刊:Jama Oncology

影响因子:20.1

doi:10.1001/jamaoncol.2019.0096

Fendler, Wolfgang P; Calais, Jeremie; Eiber, Matthias; Flavell, Robert R; Mishoe, Ashley; Feng, Felix Y; Nguyen, Hao G; Reiter, Robert E; Rettig, Matthew B; Okamoto, Shozo; Emmett, Louise; Zacho, Helle D; Ilhan, Harun; Wetter, Axel; Rischpler, Christoph; Schoder, Heiko; Burger, Irene A; Gartmann, Jeannine; Smith, Raven; Small, Eric J; Slavik, Roger; Carroll, Peter R; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A

A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study

一项针对前列腺活检患者的移动医疗干预措施可减少预约取消：队列研究

期刊:Journal of Medical Internet Research

影响因子:6

doi:10.2196/14094

Balakrishnan, Ashwin S; Nguyen, Hao G; Shinohara, Katsuto; Au Yeung, Reuben; Carroll, Peter R; Odisho, Anobel Y

发表日期：2019

文献求助收藏

The use of prostate MR for targeting prostate biopsies

利用前列腺磁共振成像进行前列腺活检

期刊:BJRopen

影响因子:2.1

doi:10.1259/bjro.20180044

Kelley, R Phelps; Zagoria, Ronald J; Nguyen, Hao G; Shinohara, Katsuto; Westphalen, Antonio C

发表日期：2019

文献求助收藏

Phase I Study of CTT1057, an (18)F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer

CTT1057（一种靶向前列腺癌特异性膜抗原的磷酰胺核心的（18）F标记显像剂）的I期研究

期刊:

影响因子:

doi:10.2967/jnumed.118.220715

Behr, Spencer C; Aggarwal, Rahul; VanBrocklin, Henry F; Flavell, Robert R; Gao, Kenneth; Small, Eric J; Blecha, Joseph; Jivan, Salma; Hope, Thomas A; Simko, Jeffry P; Kurhanewicz, John; Noworolski, Susan M; Korn, Natalie J; De Los Santos, Romelyn; Cooperberg, Matthew R; Carroll, Peter R; Nguyen, Hao G; Greene, Kirsten L; Langton-Webster, Beatrice; Berkman, Clifford E; Seo, Youngho

Small-molecule RNA therapeutics to target prostate cancer.

利用小分子RNA疗法治疗前列腺癌

Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma

原发性前列腺腺癌选择性前列腺动脉和静脉注射PSMA PET/CT放射性配体输注的药代动力学比较

The natural history of a delayed detectable PSA after radical prostatectomy

根治性前列腺切除术后延迟检测到PSA的自然史

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial

在2期临床试验中，恩扎卢胺联合亮丙瑞林和根治性放射治疗对高危局限性或区域性非转移性前列腺癌具有良好的耐受性和疗效。

US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy

美国超声病灶可见性可预测系统性活检所显示的具有临床意义的前列腺癌分级升级

Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial

68Ga-PSMA-11 PET在根治性前列腺切除术和盆腔淋巴结清扫术前检测盆腔淋巴结转移的诊断准确性：一项多中心前瞻性3期影像学试验

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

评估 68Ga-PSMA-11 PET 在定位复发性前列腺癌中的准确性：一项前瞻性单臂临床试验

A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study

一项针对前列腺活检患者的移动医疗干预措施可减少预约取消：队列研究

The use of prostate MR for targeting prostate biopsies

利用前列腺磁共振成像进行前列腺活检

Phase I Study of CTT1057, an (18)F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer

CTT1057（一种靶向前列腺癌特异性膜抗原的磷酰胺核心的（18）F标记显像剂）的I期研究